Last reviewed · How we verify
Placebo to match solifenacin succinate — Competitive Intelligence Brief
phase 3
Urology
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo to match solifenacin succinate (Placebo to match solifenacin succinate) — Astellas Pharma Europe B.V.. This is a placebo formulation designed to match the appearance and administration of solifenacin succinate for blinded clinical trial purposes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo to match solifenacin succinate TARGET | Placebo to match solifenacin succinate | Astellas Pharma Europe B.V. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo to match solifenacin succinate CI watch — RSS
- Placebo to match solifenacin succinate CI watch — Atom
- Placebo to match solifenacin succinate CI watch — JSON
- Placebo to match solifenacin succinate alone — RSS
Cite this brief
Drug Landscape (2026). Placebo to match solifenacin succinate — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-match-solifenacin-succinate. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab